Sinclair IS Pharma Articles
Sinclair IS partners with Quintiles to commercialize portfolio in Mexico
13 September 2012
Sinclair IS buys derma company
8 December 2011
Sinclair IS Pharma divests Mysoline to Lab SERB for £11 million
15 November 2011
Sinclair IS in Episil licensing deal with Teva
1 September 2011
UK drugmakers Sinclair and IS Pharma confirm merger
11 April 2011
Showing 1-7 of 7 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
